source
- Biotech layoffs are easing, but is the worst over?BioNTech is one of the most recent companies to announce cuts, but the pace of job losses is slowing.BioPharma Dive · 2mo ago↗ source
- Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTR. Lor Randall, MD, FACS discusses safety and efficacy data from the MANEUVER trial, which evaluated pimicotinib in TGCT.onclive · 2mo ago↗ source
- Renal Cell Carcinoma: Real-World Factors in First-Line Treatment SelectionIn this segment, Dr. Elizabeth Plimack and Dr. Yasser Ged discuss how real-world patient factors influence first-line treatment decisions in renal cell carcinoma.onclive · 2mo ago↗ source